We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOLB:EURONEXT BRUSSELSSolvay SA Analysis

Data as of 2026-05-25 - not real-time

€26.20

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Solvay trades around €26, just above its DCF‑derived fair value, indicating limited upside. The stock offers a high single‑digit dividend yield, backed by a very low payout ratio, suggesting sustainability. Technicals show a bearish MACD histogram and decreasing volume, pointing to short‑term pressure. RSI sits near the mid‑range, and the price is comfortably above the identified support but still below the near‑term resistance. Beta is exceptionally low, implying minimal market‑wide price swings, yet 30‑day volatility exceeds 30%, reflecting internal price swings. Recent shareholder meeting minutes reveal strong backing for management’s strategy, adding governance confidence.
Fundamentals reveal flat to negative revenue growth and modest margins, limiting organic growth prospects. The balance sheet carries a high debt‑to‑equity ratio, but ample cash and positive free cash flow cushion liquidity. The valuation metrics place the stock in the “value” camp, with a forward P/E around 10 and a price‑to‑book above 2.5. Given the combination of a generous dividend, defensive beta, and modest valuation headroom, the stock is best viewed as a dividend‑focused value play. Investors should be cautious of the bearish short‑term technical signals and the sector’s sensitivity to commodity cycles. Overall, the recommendation leans toward holding with a view to accumulate on dips while monitoring cash flow and debt trends.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Decreasing trading volume
  • Price near mid‑range resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • High single‑digit dividend yield with low payout ratio
  • DCF fair value close to market price suggesting limited downside
  • Strong shareholder support for strategic direction

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend backed by solid free cash flow
  • Defensive beta and low market‑wide volatility
  • Strategic exposure to battery and specialty chemicals markets

Key Metrics & Analysis

Financial Health

Revenue Growth-8.10%
Profit Margin-0.54%
P/E Ratio9.9
ROE-1.46%
ROA4.05%
Debt/Equity185.94
P/B Ratio2.7
Op. Cash Flow€660.0M
Free Cash Flow€340.5M

Technical Analysis

TrendNeutral
RSI45.6
Support€24.56
Resistance€29.16
MA 20€26.83
MA 50€26.78
MA 200€27.06
MACDBearish
VolumeDecreasing
Fear & Greed Index91.75

Valuation

Fair Value€26.19
Target Price€24.94
Upside/Downside-4.79%
GradeOvervalued
TypeValue
Dividend Yield9.35%

Risk Assessment

Beta0.08
Volatility31.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.